Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Cell Reports
|
February 15, 2018
β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion
Marianne Böni-Schnetzler, Stéphanie P Häuselmann, Elise Dalmas, et al.
Diabetes
|
October 30, 2014
Angiotensin II induces interleukin-1β-mediated islet inflammation and β-cell dysfunction independently of vasoconstrictive effects
Nadine S Sauter, Constanze Thienel, Yuliya Plutino, et al.
Frontiers in Endocrinology
|
September 26, 2024
Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome-the FertIL trial
Milica Wälchli-Popovic, Sophie Monnerat, Angela E Taylor, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
April 4, 2014
Interleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice
Stephan Wueest, Flurin Item, Christina N Boyle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 22, 2015
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Claudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2008
Interleukin-6 regulates pancreatic alpha-cell mass expansion
Helga Ellingsgaard, Jan A Ehses, Eva B Hammar, et al.
Cell Reports
|
March 30, 2017
Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
Shuyang Traub, Daniel T Meier, Friederike Schulze, et al.
Nature Communications
|
August 13, 2022
Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing
Daniel T Meier, Leila Rachid, Sophia J Wiedemann, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 16, 2019
Treatment of Primary Aldosteronism With mTORC1 Inhibitors
Beckey Trinh, Matthias Hepprich, Matthias J Betz, et al.
Lancet (London, England)
|
July 27, 2020
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Gerd R Burmester, Frank Buttgereit, Corrado Bernasconi, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Cell Reports
|
February 15, 2018
β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion
Marianne Böni-Schnetzler, Stéphanie P Häuselmann, Elise Dalmas, et al.
Diabetes
|
October 30, 2014
Angiotensin II induces interleukin-1β-mediated islet inflammation and β-cell dysfunction independently of vasoconstrictive effects
Nadine S Sauter, Constanze Thienel, Yuliya Plutino, et al.
Frontiers in Endocrinology
|
September 26, 2024
Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome-the FertIL trial
Milica Wälchli-Popovic, Sophie Monnerat, Angela E Taylor, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
April 4, 2014
Interleukin-6 contributes to early fasting-induced free fatty acid mobilization in mice
Stephan Wueest, Flurin Item, Christina N Boyle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 22, 2015
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Claudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 23, 2008
Interleukin-6 regulates pancreatic alpha-cell mass expansion
Helga Ellingsgaard, Jan A Ehses, Eva B Hammar, et al.
Cell Reports
|
March 30, 2017
Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
Shuyang Traub, Daniel T Meier, Friederike Schulze, et al.
Nature Communications
|
August 13, 2022
Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing
Daniel T Meier, Leila Rachid, Sophia J Wiedemann, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 16, 2019
Treatment of Primary Aldosteronism With mTORC1 Inhibitors
Beckey Trinh, Matthias Hepprich, Matthias J Betz, et al.
Lancet (London, England)
|
July 27, 2020
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Gerd R Burmester, Frank Buttgereit, Corrado Bernasconi, et al.
Page
of 13